Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aimmune Therap (NQ: AIMT )

34.49 USD UNCHANGED
Last Price Updated: 7:11 PM EDT, Oct 12, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Aimmune Therap

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Here's Why Aimmune Therapeutics Stock Jumped on Wednesday
A survey of allergists suggests Palforzia's launch could be more successful than expected. 
Tags Market News AIMT
From Motley Fool
AIMT Makes Bullish Cross Above Critical Moving Average
In trading on Wednesday, shares of Aimmune Therapeutics Inc (AIMT) crossed above their 200 day moving average of $21.59, changing hands as high as $23.63 per share. Aimmune Therapeutics Inc shares are... 
Tags Stocks
From Market News Video
31 Stocks Moving In Wednesday's Mid-Day Session
Gainers The Stars Group Inc. (NASDAQ: TSG) shares jumped 33% to $20.36 after the company announced an all-stock merger with ... 
Tags XXII NEPT RESN
From Benzinga
Shares of Aimmune Therapeu Down on Above Average Volume, Moving Against Trend (AIMT)
Aimmune Therapeu shares are trading on heavy volume today, having fallen -9.7% to $22.45. Approximately 2.0 million shares have changed hands today vs. average 30-day volume of 1.2 million... 
From Comtex SmarTrend® News Briefs
25 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Gainers Immuron, Inc. (NASDAQ: IMRN) shares surged 34.3% to $3.60 during Wednesday's pre-market session. The market cap stands ... 
Tags Benzinga NTEC JAGX
From Benzinga
23 Stocks Moving in Wednesday's Pre-Market Session
Gainers The Stars Group Inc. (NASDAQ: TSG) shares rose 44.1% to $22.06 in pre-market trading after the company announced an ... 
Tags LEN Trading Ideas KL
From Benzinga
The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data
Here's a roundup of top developments in the biotech space over the last 24 hours. None of the NYSE/Nasdaq-listed biotech stocks ... 
Tags Top Stories ASRT NVS
From Benzinga
First Week of AIMT November 15th Options Trading
Investors in Aimmune Therapeutics Inc (AIMT) saw new options begin trading this week, for the November 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AIMT... 
Tags Stocks
From Market News Video
Pick Up This Deal Even Lower Than Chief Financial Officer Bjerkholt Did
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 18, Aimmune Therapeutics Inc's Chief Financial... 
Tags Stocks
From Market News Video
Will Vaping Deaths Derail Marijuana Stocks? Plus, a New Treatment for Peanut Allergies Advances
How vaping risks may impact cannabis companies and Aimmune Therapeutics' plan to change how doctors treat peanut allergies. 
Tags AIMT Market News
From Motley Fool
How The Parts Add Up: VHT Headed For $199
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Analyst: DBV's Peanut Allergy Drug Could Outscore Aimmune's On Safety Front
Aimmune Therapeutics Inc (NASDAQ: AIMT)'s peanut allergy product candidate Palforzia to treat peanut allergy in children and ... 
Tags AIMT H/C/ Wainwright Biotech
From Benzinga
Profit-Takers Drag This Highflying Biotech Stock Into The Red
Aimmune stock toppled Monday on profit-taking after the biotech company's peanut allergy treatment gained a key recommendation from the FDA's Allergenic Products Advisory Committee. 
From Investor's Business Daily
A Look At Benzinga Pro's Most-Searched Tickers For September 16, 2019
This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga ... 
Tags YUMA SDC Market News
From Benzinga
Shares of Aimmune Therapeu Are Down on Strong Volume (AIMT)
Aimmune Therapeu shares are trading on heavy volume today, having fallen 2.9% to $23.95. Today's volume of 1.5 million shares tops the average 30-day volume of 906,000 shares. ... 
From Comtex SmarTrend® News Briefs
25 Stocks Moving in Monday's Pre-Market Session
Gainers Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR) rose 80.9% to $18.20 in pre-market trading after Danish company Lundbeck ... 
Tags SWN YUMA ROAD
From Benzinga
A Mixed FDA Panel Just Recommended This Biotech's Peanut Allergy Drug
A Food and Drug Administration panel determined Friday the benefits of Aimmune Therapeutics' peanut allergy treatment outweigh the risks. The panel voted 8-1 in favor of the drug's safety. 
From Investor's Business Daily
First peanut allergy therapy gets backing from U.S. regulators' expert advisers
A U.S. Food and Drug Administration advisory panel on Friday recommended approving the first therapy for peanut allergies, which affect over 1.6 million children in the United States, despite raising... 
Tags companyNews
From Reuters: Company News
24 Stocks Moving in Friday's Pre-Market Session
Gainers Mer Telemanagement Solutions Ltd. (NASDAQ: MTSL) rose 73.3% to $2.08 in pre-market trading after reporting half-year ... 
Tags Financials CYAD Diversified Banks
From Benzinga
The Daily Biotech Pulse: All Eyes On Aimmune, Ritter Stumbles In Late-Stage Study, Catalyst Shelves Offering Plans
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags HALO RTTR FDA
From Benzinga
28 Healthcare Stocks Moving In Thursday's Pre-Market Session
Gainers SINTX Technologies, Inc. (NASDAQ: SINT) shares increased by 38.0% to $2.07 during Thursday's pre-market session. The ... 
Tags SINT MRNA Biotechnology
From Benzinga
71 Biggest Movers From Yesterday
Gainers T2 Biosystems, Inc. (NASDAQ: TTOO) shares jumped 82.5% to close at $2.61 on Wednesday after the company announced that it ... 
Tags ENOB IQ VRCA
From Benzinga
Did the FDA Just Signal Smooth Sailing Ahead For Aimmune Therapeutics?
Here's what a benign briefing document means, and what it doesn't. 
Tags AIMT Market News
From Motley Fool
Potential Peanut Allergy Treatment Gives Pharma Company A Boost
Most people are aware that peanuts can cause a severe, potentially life-threatening allergic reactions, which can be unpredictable, and even minuscule amounts of peanut can cause a disaster. While... 
Tags AIMT Innovative ETFs Channel PJP
From ETF Trends
Notable Wednesday Option Activity: VIAV, AIMT, ACHC
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Viavi Solutions Inc (VIAV), where a total volume of 63,140 contracts has been... 
Tags Stocks
From Market News Video
Here's Why Aimmune Therapeutics Stock Is Surging Today
The company's peanut allergen desensitization therapy took an indirect step forward. 
Tags AIMT Market News
From Motley Fool
48 Stocks Moving In Wednesday's Mid-Day Session
Gainers Yuma Energy, Inc. (NYSE: YUMA) shares jumped 130% to $4.1821 after the company announced a third-party has purchased all ... 
Tags FRAN LOVE Benzinga
From Benzinga
Why This Peanut Allergy-Focused Biotech Stock Rocketed In Huge Volume
Aimmune Therapeutics stock rocketed to a six-month high Wednesday ahead of a Food and Drug Administration committee meeting to discuss the biotech company's peanut allergy treatment. 
From Investor's Business Daily
Aimmune Therapeu Rising Today on Above-Average Volume (AIMT)
The price of Aimmune Therapeu shares has climbed to $24.45 (a 10.8% change) on heavy trading volume. About 1.5 million shares have been traded today, as compared to the... 
From Comtex SmarTrend® News Briefs
Biotech Stock On The Radar: Aimmune Awaits Adcom Test
Aimmune Therapeutics Inc (NASDAQ: AIMT) shares have been on an extended downtrend since the start of 2018. This thinly traded, ... 
Tags Brian Skorney News General
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback